Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-07-095857
Filing Date
2007-04-30
Accepted
2007-04-30 15:51:30
Documents
3
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT d10ka.htm 10-K/A 251151
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6588
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6555
  Complete submission text file 0001193125-07-095857.txt   265847
Mailing Address 155 FEDERAL STREET BOSTON MA 02110
Business Address 155 FEDERAL STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23776 | Film No.: 07800258
SIC: 2834 Pharmaceutical Preparations